Dietary strategies to help fibromyalgia in overweight or obese women
Official title: Impact of Different Dietary Strategies in the Management of Overweight and Obesity in Patients With Fibromyalgia: Effects on Pain, Disease Severity, Nutritional and Metabolic Profile, Gut Microbiota and Microbial Metabolites, and Brain GABA and Glutamate Levels
Run by Universita degli Studi di Genova · NCT07517757 · Data updated 2026-11-12
This trial tests whether a very low-calorie ketogenic diet, a Mediterranean diet, or a Mediterranean diet with a probiotic can reduce fibromyalgia symptoms in overweight or obese women.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | Women only |
| Enrollment | 90 (estimated) |
| Sponsor | Universita degli Studi di Genova Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Genova, Genova) |
| Status | Recruiting |
| Started | April 10, 2026 |
| Main results expected | December 2027 |
| Study ends | June 2028 |
| Registry record updated | September 30, 2026 |
| Trial ID | NCT07517757 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adult women with fibromyalgia, aged 18–65, who are overweight or class I obesity (BMI 25–34.9) and can commit to dietary plans.
✕Probably not a fit
Patients unlikely to benefit may include those with severe comorbidities, intolerance to study diets, or adherence difficulties.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, parallel-arm study compares three dietary approaches in female adults with fibromyalgia and overweight or obesity. Participants will be assigned to a very low-calorie ketogenic diet, a Mediterranean diet, or a Mediterranean diet enriched with a probiotic that can produce GABA. The study will measure fibromyalgia severity, sleep, anxiety, and depression using validated questionnaires, along with changes in body composition, metabolic profile, and gut microbiota. Additional analyses include neurosteroid markers and, in a subset, brain GABA and glutamate by MR spectroscopy. The trial is conducted at Genoa-based rheumatology and internal medicine centers and is sponsored by the University of Genoa.
Why it matters
Potential benefit: If successful, the dietary approaches could offer nonpharmacologic options to help reduce pain and improve quality of life for people with fibromyalgia.
How similar studies have gone: Previous research suggests diet can influence pain and metabolic factors, but this specific multi-diet randomized approach in fibromyalgia is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult female patients with fibromyalgia, aged ≤ 65 years, who are overweight or obese (BMI 24.9 \< ≤34.9 kg/m2); * Patients able to independently provide their written informed consent to participate in the study; * Patients motivated to participate in the project and able to independently manage the dietary plans provided for in the study. Exclusion Criteria: * Lack of signature on informed consent form * Age \< 18 and \> 65 years * Male gender * Patients with food allergies or celiac disease, type 1 diabetes mellitus and autoimmune forms of diabetes mellitus or with severe pancreatic beta cell dysfunction, undergoing treatment with SGLT2 inhibitors, with recent cardiovascular or cerebrovascular events, liver failure, moderate or severe renal failure, respiratory failure, episodes of gout, kidney stones, electrolyte disturbances, NYHA class III-IV heart failure, unstable angina, cardiac arrhythmias or myocardial infarction within the last 12 months, severe depression or any other psychiatric illness, drug, narcotic or alcohol abuse, frail patients, pregnancy and/or breastfeeding, patients about to undergo surgery or invasive procedures, rare diseases (porphyria, carnitine deficiency, carnitine palmitoyltransferase, carnitine acylcarnitine translocase and pyruvate carboxylase, mitochondrial beta oxidation disorders), treatment with diuretics. * Use of prebiotics and/or probiotics not included in the study, or other dietary supplements in the month prior to enrollment * Antibiotic treatment less than 3 months prior to enrollment * Infections at the time of enrollment or any chronic gastrointestinal disorder (e.g., Crohn's disease) * Significant eating problems (e.g., dysphagia).
Where it's running
-
Department of Internal and Medical Specialities (university of Genoa)
Genova, Genova, Italy Recruiting
Study contacts
- Study coordinator: Alberto Sulli, Professor
- Email: alberto.sulli@unige.it
- Phone: 010-35338710
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Whole-body Cryotherapy for Fatigue in ME/CFS, Fibromyalgia, Long COVID
This study tests whether brief, repeated exposure to extreme cold can help reduce fatigue and related symptoms in adults with ME/CFS, fibromyalgia, or Long COVID compared to healthy controls.
-
Noninvasive brain stimulation to see if it lowers pain in fibromyalgia
This study tests whether daily noninvasive brain stimulation can reduce pain and improve quality of life for people with fibromyalgia, using two brain targets and a crossover design.
-
Home-based high-dose tDCS for fibromyalgia: predicting response and comparing brain targets
This study tests whether a high-dose home-based tDCS treatment is at least as good as the conventional home-based tDCS for people with fibromyalgia, and whether it could be better, while also checking if baseline EEG can predict who responds.
-
Isokinetic microdose exercise for women with fibromyalgia
This 8-week program will test whether low-dose isokinetic exercise helps women with fibromyalgia reduce pain, improve strength, and enhance quality of life.
-
Does hardaliye help fibromyalgia when added to a personalized diet?
This study tests whether a traditional grape-based drink called hardaliye, used with a personalized diet, can improve symptoms and inflammation in adult women with fibromyalgia.
-
Personalized ultrasonic brain stimulation to reduce fibromyalgia symptoms
This study will test whether personalized low-intensity ultrasound to the brain can reduce pain and other symptoms in adults with fibromyalgia who have not improved after standard medications and physical therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.